ARTICLE | Company News
Incara deal
January 4, 2000 8:00 AM UTC
INCR sold for $11 million in cash its antibacterial drug discovery division, Incara Research Laboratories, to an undisclosed party. INCR also is eligible for $4 million in milestones from Merck & Co....